BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37739333)

  • 1. Associations between polymorphisms in the cannabinoid receptor 1 gene, cognitive impairments and tardive dyskinesia in a Chinese population with schizophrenia.
    Lu C; Li S; Li Y; Zhang X; Chi J; Jiang Q; Ma Y; Shi X; Wang L; Li J
    Brain Res; 2023 Dec; 1821():148579. PubMed ID: 37739333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between Catechol-O-methyltransferase (COMT) polymorphisms and cognitive impairments, psychiatric symptoms and tardive dyskinesia in schizophrenia.
    Chi J; Ma Y; Shi M; Lu C; Jiang Q; Li Y; Zhang X; Shi X; Wang L; Li S
    Brain Res; 2024 Mar; 1826():148740. PubMed ID: 38142723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
    Hui L; Han M; Yin GZ; Zhang Y; Huang XF; Qian ZK; Gu WG; Gu XC; Zhu XM; Soares JC; Ning Y; Zheng Y; Du XD; Zhang XY
    Schizophr Res; 2017 Apr; 182():104-109. PubMed ID: 27776953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
    Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment.
    Liang Q; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    J Psychiatr Res; 2022 Jul; 151():181-187. PubMed ID: 35489178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes.
    Jiang Q; Zhang X; Lu X; Li Y; Lu C; Chi J; Ma Y; Shi X; Wang L; Li S
    Neuropsychiatr Dis Treat; 2023; 19():2499-2509. PubMed ID: 38029048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
    Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.
    Tiwari AK; Zai CC; Likhodi O; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Müller DJ; Kennedy JL
    Pharmacogenomics J; 2012 Jun; 12(3):260-6. PubMed ID: 21266946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic Polymorphisms.
    Uludag K; Wang DM; Zhang XY
    Oxid Med Cell Longev; 2022; 2022():5748924. PubMed ID: 36338339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
    Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
    Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia.
    Lu JY; Tiwari AK; Zai GC; Rastogi A; Shaikh SA; Müller DJ; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Wong AHC; Kennedy JL; Zai CC
    Neurosci Lett; 2018 Nov; 686():17-22. PubMed ID: 30118782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study between the neurexin-1 gene and tardive dyskinesia.
    Lanning R; Lett TA; Tiwari AK; Brandl EJ; de Luca V; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Remington G; Kennedy JL; Zai CC
    Hum Psychopharmacol; 2017 Jan; 32(1):. PubMed ID: 28120489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrosequencing analysis of IRS1 methylation levels in schizophrenia with tardive dyskinesia.
    Li Y; Wang K; Zhang P; Huang J; Liu Y; Wang Z; Lu Y; Tan S; Yang F; Tan Y
    Mol Med Rep; 2020 Apr; 21(4):1702-1708. PubMed ID: 32319643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.
    Liou YJ; Wang YC; Chen JY; Bai YM; Lin CC; Liao DL; Chen TT; Chen ML; Mo GH; Lai IC
    Psychiatry Res; 2007 Dec; 153(3):271-5. PubMed ID: 17669510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of tardive dyskinesia: an updated review of the literature.
    Lanning RK; Zai CC; Müller DJ
    Pharmacogenomics; 2016 Aug; 17(12):1339-51. PubMed ID: 27469238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of rs1076560 (DRD2) and rs4680 (COMT) on tardive dyskinesia and cognition in schizophrenia subjects.
    Punchaichira TJ; Kukshal P; Bhatia T; Deshpande SN; Thelma BK
    Psychiatr Genet; 2020 Oct; 30(5):125-135. PubMed ID: 32931693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.
    Zai CC; Tiwari AK; Chowdhury NI; Yilmaz Z; de Luca V; Müller DJ; Potkin SG; Lieberman JA; Meltzer HY; Voineskos AN; Remington G; Kennedy JL
    World J Biol Psychiatry; 2019 Jan; 20(1):91-95. PubMed ID: 28394697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.